Sheet Spf 30 Mineral
Titanium Dioxide, Zinc Oxide
Vivier Pharma Inc.
Human Otc Drug
NDC 67226-2232Sheet Spf 30 Mineral also known as Titanium Dioxide, Zinc Oxide is a human otc drug labeled by 'Vivier Pharma Inc.'. National Drug Code (NDC) number for Sheet Spf 30 Mineral is 67226-2232. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Sheet Spf 30 Mineral drug includes Titanium Dioxide - 100 mg/mL Zinc Oxide - 80 mg/mL . The currest status of Sheet Spf 30 Mineral drug is Active.
Drug Information:
| Drug NDC: | 67226-2232 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Sheet Spf 30 Mineral |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Titanium Dioxide, Zinc Oxide |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Vivier Pharma Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Lotion |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | TITANIUM DIOXIDE - 100 mg/mL
ZINC OXIDE - 80 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 04 Jan, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 16 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Vivier Pharma Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0696163800337
|
| UPC stands for Universal Product Code. |
| UNII: | 15FIX9V2JP
SOI2LOH54Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 67226-2232-6 | 1 BOTTLE in 1 BOX (67226-2232-6) / 60 mL in 1 BOTTLE | 04 Jan, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose sunscreen
Product Elements:
Sheet spf 30 mineral titanium dioxide, zinc oxide aluminum oxide ammonium acryloyldimethyltaurate/vp copolymer bis-peg/ppg-16/16 peg/ppg-16/16 dimethicone butylparaben alkyl (c12-15) benzoate medium-chain triglycerides polyoxyl 20 cetostearyl ether cetostearyl alcohol orange peel lemon peel cyclomethicone 6 cyclomethicone 5 dipropylene glycol dibenzoate .alpha.-tocopherol acetate, dl- ethylparaben glycerin glyceryl monostearate green tea leaf ferric oxide red ferric oxide yellow ferrosoferric oxide isopropyl titanium triisostearate methylparaben phenoxyethanol fytic acid polysorbate 20 ppg-15 stearyl ether benzoate propylene glycol propylparaben apple sugarcane sodium ascorbyl phosphate sodium hydroxide tert-butyl alcohol triethoxycaprylylsilane water xanthan gum titanium dioxide titanium dioxide zinc oxide zinc oxide
Indications and Usage:
Uses helps prevent sunburn and provides a sun protection factor of 30. broad spectrum. ideal for daily use; can be applied under makeup.
Warnings:
Warnings for external use only. do not use on damaged or broken skin. when using this product avoid contact with eyes. if contact occurs, rinse thoroughly with water. stop use and ask a doctor if rash occurs. other warnings skin cancer/skin aging alert: spending time in the sun increases your risk of skin cancer and early skin aging. this product has been shown only to help prevent sunburn, not skin cancer or early skin aging. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Do Not Use:
Warnings for external use only. do not use on damaged or broken skin. when using this product avoid contact with eyes. if contact occurs, rinse thoroughly with water. stop use and ask a doctor if rash occurs. other warnings skin cancer/skin aging alert: spending time in the sun increases your risk of skin cancer and early skin aging. this product has been shown only to help prevent sunburn, not skin cancer or early skin aging. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
When Using:
When using this product avoid contact with eyes. if contact occurs, rinse thoroughly with water.
Dosage and Administration:
Directions adults and children over 6 months of age: apply liberally and evenly 15 minutes before sun exposure. reapply at least every 2 hours. sun protection measures: spending time in the sun increase your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: - limits time in the sun, especially from 10 a.m.2 p.m. ; and wear long-sleeved shirts, pants, hats, and sunglasses.
Stop Use:
Stop use and ask a doctor if rash occurs.
Package Label Principal Display Panel:
Package labeling: label label2
Further Questions:
Questions? call 1 877 484 8437